Addressing Cancer with Pseudoglucose Introduction to Frustrate ATP Production in Tumor Cells
While ordinary, healthy cells in the human body enjoy a reasonably efficient glucose-ATP conversion, creating on the average 36 ATP molecules for every glucose, tumor cells across all classes of cancer have a notoriously inefficient process of glycolysis, creating only about four ATPs with a glucose. It has long been standard treatment protocol to keep cancer patients on sugar-free, low-calorie diets in order to slow tumor growth.
One simple way to address the problem that has not yet been explored would be to flood the body with synthetic molecules that are chemically similar enough to glucose that they will be accepted by the mitochondria of all cells in the human body as well as by tumor cells. Where healthy cells enjoy an efficient glucose-ATP conversion process that would likely be able to keep healthy tissues alive even with every other molecule healthy mitochondria encounter being a pseudoglucose and every other one being a true glucose, a tumor cell, with its extremely inefficient process, would likely be overwhelmed and would eventually lead to cell apoptosis in tumor cells. This process is analogous to the way in which an engine with six cylinders may be able to run adequately on five cylinders, but an engine with only four cylinders to begin with may have significantly more difficulty running on three.
Rather than trying to selectively poison undesired cells (chemotherapy), we should attempt to selectively starve tumor cells by taking advantage of a known feature of tumor cells. A safe-to-use pseudoglucose that would not cause harmful side-effects and would break down into a safe, inert chemical would need to be developed and tested before a treatment may be established along these lines, however, if successful, future cancers may be addressed with a nutritional supplement in the form of a water-soluble powder taken 4 times daily.
While ordinary, healthy cells in the human body enjoy a reasonably efficient glucose-ATP conversion, creating on the average 36 ATP molecules for every glucose, tumor cells across all classes of cancer have a notoriously inefficient process of glycolysis, creating only about four ATPs with a glucose. It has long been standard treatment protocol to keep cancer patients on sugar-free, low-calorie diets in order to slow tumor growth.
One simple way to address the problem that has not yet been explored would be to flood the body with synthetic molecules that are chemically similar enough to glucose that they will be accepted by the mitochondria of all cells in the human body as well as by tumor cells. Where healthy cells enjoy an efficient glucose-ATP conversion process that would likely be able to keep healthy tissues alive even with every other molecule healthy mitochondria encounter being a pseudoglucose and every other one being a true glucose, a tumor cell, with its extremely inefficient process, would likely be overwhelmed and would eventually lead to cell apoptosis in tumor cells. This process is analogous to the way in which an engine with six cylinders may be able to run adequately on five cylinders, but an engine with only four cylinders to begin with may have significantly more difficulty running on three.
Rather than trying to selectively poison undesired cells (chemotherapy), we should attempt to selectively starve tumor cells by taking advantage of a known feature of tumor cells. A safe-to-use pseudoglucose that would not cause harmful side-effects and would break down into a safe, inert chemical would need to be developed and tested before a treatment may be established along these lines, however, if successful, future cancers may be addressed with a nutritional supplement in the form of a water-soluble powder taken 4 times daily.
